|
|||||
|
|
Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase‐5A inhibitor vardenafil in rats with type 2 diabetes |
|
| Authors: | Csaba Mátyás Balázs T. Németh Attila Oláh Marianna Török Mihály Ruppert Dalma Kellermayer Bálint A. Barta Gábor Szabó Gábor Kökény Eszter M. Horváth Beáta Bódi Zoltán Papp Béla Merkely Tamás Radovits |
| Affiliation: | 1. Experimental Research Laboratory, Heart and Vascular Center, Semmelweis University, Budapest, Hungary;2. Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany;3. Institute of Pathophysiology, Semmelweis University, Budapest, Hungary;4. Department of Physiology, Semmelweis University, Budapest, Hungary;5. Division of Clinical Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary |
| Abstract: | |
| Keywords: | Vardenafil cGMP Diabetic cardiomyopathy Diastolic dysfunction Cardiomyocyte stiffness |